| Typicality: | 0.623 |
| Saliency: | 0.592 |
| in december | 14 | temporal |
| for human testing | 12 | purpose |
| for a new use | 11 | purpose |
| drug → receive → fda approval | 85 |
| drug → win → fda approval | 38 |
| drug → gain → fda approval | 35 |
| drug → received → fda approval | 24 |
| drug → get → fda approval | 22 |
| drug → have → fda approval | 18 |
| drug → be received → fda approval | 6 |
| drug → be granted → fda approval | 6 |
| drug → obtain → fda approval | 5 |
| drug → get → an fda approval | 4 |
| drug → gained → fda approval | 3 |
| drug → earn → fda approval | 3 |
| drug → be given → fda approval | 3 |
| drug → garner → fda approval | 3 |
| negative | neutral | positive |
| 0.148 | 0.543 | 0.309 |
| Raw frequency | 255 |
| Normalized frequency | 0.592 |
| Modifier score | 0.871 |
| Perplexity | 248.352 |